miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)

Taruna Arora1, Mohd Adnan Kausar2, Shimaa Mohammed Aboelnaga3

  • 1Division of Reproductive Biology, Maternal & Child Health, Department of Health Research, ICMR, MOHFW, Government of India, Ansari Nagar, New Delhi 110029, India.

Oncology Reports
|June 14, 2022
PubMed

Insights

The hippo signaling pathway and microRNAs (miRNAs) are crucial in cancer development. Understanding their complex interplay offers new avenues for effective cancer therapeutics and overcoming drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer is a leading global cause of death, often linked to cellular dysregulation.
  • The hippo signaling pathway controls organ size by regulating cell proliferation and apoptosis.
  • MicroRNAs (miRNAs), non-coding RNAs, are implicated in various cancers and regulate gene expression.

Purpose of the Study:

  • To elucidate the intricate mechanisms of the hippo signaling pathway and miRNA biogenesis.
  • To explore the cross-regulatory links between miRNAs and the hippo pathway in cancer.
  • To review miRNA-based therapeutics and the challenge of anticancer drug resistance.

Main Methods:

  • Literature review focusing on molecular mechanisms.
  • Analysis of the interplay between hippo pathway components and miRNA regulation.
  • Synthesis of current research on miRNA therapeutics and drug resistance.

Main Results:

  • Dysregulation of the hippo pathway can lead to cancer-like conditions.
  • miRNAs and the hippo pathway exhibit complex cross-regulatory interactions.
  • Altered miRNA expression is a hallmark of various cancer types.

Conclusions:

  • Understanding the hippo pathway-miRNA axis is vital for cancer biology.
  • Targeting miRNAs presents a promising therapeutic strategy for cancer treatment.
  • Addressing drug resistance mechanisms is essential for improving patient outcomes.

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K